Does DARATUMUMAB Cause Transplant? 88 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Transplant have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.3% of all adverse event reports for DARATUMUMAB.
88
Reports of Transplant with DARATUMUMAB
0.3%
of all DARATUMUMAB reports
4
Deaths
16
Hospitalizations
How Dangerous Is Transplant From DARATUMUMAB?
Of the 88 reports, 4 (4.5%) resulted in death, 16 (18.2%) required hospitalization.
Is Transplant Listed in the Official Label?
Yes, Transplant is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Transplant?
DARBEPOETIN ALFA (287)
VENETOCLAX (158)
CINACALCET (145)
MACITENTAN (71)
BORTEZOMIB (61)
EPOPROSTENOL (58)
DEXAMETHASONE (50)
AMBRISENTAN (48)
LENALIDOMIDE (46)
AZTREONAM LYSINE (43)
Which DARATUMUMAB Alternatives Have Lower Transplant Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE